News
In a report released today, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of £155.58. The company’s shares opened today ...
TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at $66.64. Discover outperforming stocks and invest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback